Skip to content
2000
Volume 13, Issue 6
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

A new series of indolizine derivatives were synthesized and screened for the antiproliferative potential against NCI 60 tumor cell line panel. The results of the study revealed a selective and good antitumor growth inhibitory activity against SNB-75 CNS cancer cell line for 1-cyanoindolizine derivative 10b. Moreover, a supplementary in vitro biological evaluation showed that compound 9d exhibited a significant farnesyltransferase inhibition activity (IC50 = 1.07 ± 0.34 μM) and could represent a lead for the development of new antitumoral chemical entities.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180812666151022221628
2016-07-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180812666151022221628
Loading

  • Article Type:
    Research Article
Keyword(s): anticancer agent; farnesyltransferase; Indolizine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test